KALA BIO, Inc. (KALA) shares skyrocketed 47.76 percent to $0.4344, gaining $0.1405 on Wednesday, after the company announced plans to deploy its first commercial artificial intelligence agent and launch a new biotech-focused AI platform.
The stock is currently trading at $0.4344 compared with its previous close of $0.2939. Shares opened at $0.45 and traded between $0.4070 and $0.5100 during the session Nasdaq. Trading volume surged to about 186.32 million shares, far exceeding the average volume of about 1.48 million shares.
KALA said it introduced its Researgency.ai platform, designed to automate key biotech workflows such as clinical trial protocol drafting, regulatory submissions, and drug safety monitoring. The company expects to deploy its first commercial AI agent within 14 days. KALA said the initiative could create recurring revenue opportunities while it continues advancing its biologics pipeline for rare eye diseases.
The stock has traded in a 52-week range of $0.2330 to $20.6000.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.